The frequent co-occurrence of TP53 alterations and cth in CLL supports both possibilities of their relation, i.e. cth resulting from TP53 disruption as well as cth leading to TP53 abnormalities and therefore more aggressive disease. This evidence concerns the gene TP53 and B-cell chronic lymphocytic leukemia.